“Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience” (2017) Archivio Italiano di Urologia e Andrologia, 89(4), pp. 272–276. doi:10.4081/aiua.2017.4.272.